Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2007-10-17
pubmed:abstractText
Currently, there are no licensed vaccines or therapeutics for the prevention or treatment of infection by the highly lethal filoviruses, Ebola virus (EBOV) and Marburg virus (MARV), in humans. We previously had demonstrated the protective efficacy of virus-like particle (VLP)-based vaccines against EBOV and MARV infection in rodents.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-1899
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
196 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S430-7
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
pubmed:affiliation
US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't